Post-earnings recap
Reported
Thu, Oct 28, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Est. EPS
—
Est. Rev
—
Impl. Move
—
ResMed's earnings report shows a strong performance in EPS, exceeding expectations. The stock reacted positively, gaining 0.20%, likely driven by the better-than-expected EPS figure. However, the lack of revenue data and guidance may leave investors cautious about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.51 | N/A | +11.85% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a sense of cautious optimism regarding the company's performance. They acknowledged market challenges but emphasized their commitment to growth.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing challenges in the market but remain focused on long-term growth.